Metabolite detection of pancreatic carcinoma by in vivo proton MR spectroscopy at 3T: Initial results

Radiologia Medica

Volumn 117, Issue 5, 2012, Pages 780-788

  Yao, X ^a   Zeng, M ^a   Wang, H ^b   Fei, S ^b   Rao, S ^a   Ji, Y ^a  

^a ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

^b GE HEALTHCARE   (China)

Author keywords

3T; Carcinoma; Magnetic Resonance; Pancreas; Spectroscopy

Indexed keywords

ASPARTIC ACID; CHOLINE; DIPEPTIDE; DRUG DERIVATIVE; GLUTAMIC ACID; GLUTAMINE; N ACETYL 1 ASPARTYLGLUTAMIC ACID; N ACETYLASPARTIC ACID; N-ACETYL-1-ASPARTYLGLUTAMIC ACID; N-ACETYLASPARTATE; TUMOR MARKER; UNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; COMPUTER PROGRAM; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS TUMOR; PATHOLOGY;

ADULT; AGED; ASPARTIC ACID; CHOLINE; DIPEPTIDES; FATTY ACIDS, UNSATURATED; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SOFTWARE; TUMOR MARKERS, BIOLOGICAL;

EID: 84864581956     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-011-0757-7     Document Type: Article

References (32)

1. Jemal A, Siegel R, Ward E, et al. (2006) Cancer statistics. CA Cancer J Clin 56:106-130
2. Association AG (1999) American Gastroenterological Association medical position statement: Epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. Gastroenterology 117:1463-1484
3. Wolfgang S, Ahmed BS, Claus K, et al. (2007) Pancreatic adenocarcinoma. Eur Radiol 17:638-649
4. Murphy M, Loosemore A, Clifton AG, et al. (2002) The contribution of proton magnetic resonance spectroscopy (1HMRS) to clinical brain tumour diagnosis. Br J Neurosurg 16:329-334 (Pubitemid 35178576)
5. Law M, Cha S, Knopp EA, et al. (2002) High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721 (Pubitemid 34215219)
6. Moller-Hartmann W, Herminghaus S, Krings T, et al. (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371-381 (Pubitemid 36097186)
7. Scheidler J, Hricak H, Vigneron DB, et al. (1999) Prostate cancer: Localization with three-dimensional proton MR spectroscopic imagingclinicopathologic study. Radiology 21:473-480 (Pubitemid 29510595)
8. Bolan PJ, DelaBarre L, Baker EH, et al. (2002) Eliminating spurious lipid sidebands in 1H MRS of breast lesions. Magn Reson Med 48: 215-222 (Pubitemid 34809409)
9. Yeung DK, Cheung HS, Tse GM (2001) Human breast lesions: Characterization with contrast-enhanced in vivo proton MR spectroscopy-initial results. Radiology 220:40-46. (Pubitemid 32577957)
10. Ross B, Michaelis T (1994) Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 10:191-247
11. Pouwels PJ, Frahm, J (1998) Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 39:53-60 (Pubitemid 28028338)
12. Kurhanewicz J, Vigneron DB, Hricak H, et al. (1996)Three-dimensional H1 MR spectroscopic imaging of the in situ human prostate with high (0.24- 0.7-cm3) spatial resolution. Radiology 198:795-805 (Pubitemid 26066301)
13. Di Costanzo A, Trojsi F, Tosetti M, et al. (2007) Proton MR spectroscopy of the brain at 3 T: An update. Eur Radiol 17:1651-1662 (Pubitemid 46909653)
14. Roebuck JR, Cecil KM, Schnall MD, et al. (1998) Human breast lesions: Characterization with proton MR spectroscopy. Radiology 209:269-275 (Pubitemid 28464677)
15. Jacobs MA, Barker PB, Bottomley PA,, et al. (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: A preliminary study. J Magn Reson Imaging 19:68-75 (Pubitemid 38055731)
16. Ronen SM, Leach MO (2001) Imaging biochemistry: Applications to breast cancer. Breast Cancer Res 3:36-40 (Pubitemid 32223651)
17. Gillies RJ, Morse DL (2005) In vivo magnetic resonance spectroscopy in cancer. Annu Rev Biomed Eng 7:287-326 (Pubitemid 41170190)
18. Howe FA, Barton SJ, Cudlip SA, et al. (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223-232 (Pubitemid 36159858)
19. Cho SG, Lee DH, Lee KY, et al. (2005) Differentiation of chronic focal pancreatitis from pancreatic carcinoma by in vivo proton magnetic resonance spectroscopy. J Comput Assist Tomogr 29:163-169 (Pubitemid 40411298)
20. Kaplan O, Kushnir T, Askenazy N, et al. (1997) Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer. Cancer Res 57:1452-1559
21. Fang F, He XH, Deng HW, et al. (2007) Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis. Cancer Sci 98:1678-1682 (Pubitemid 47487900)
22. Katz-Brull R, Rofsky NM, Lenkinski RE (2003) Breathhold abdominal and thoracic proton MR spectroscopy at 3T. Magn Reson Med 50:461-467 (Pubitemid 37082069)
23. Gruetter R, Weisdorf SA, Rajanayagan V, et al. (1998) Resolution improvements in in-vivo 1H NMR spectra with increased magnetic field strength. J Magn Reson 135:260-264 (Pubitemid 128450714)
24. Mara M. Barth, Martin P (2007) Body MR imaging at 3.0 T: understanding the opportunities and challenges. Radiographics 27:1445-1464
25. Zeisel SH, Blusztajn JK (1994) Choline and human nutrition. Annu Rev Nutr 14:269-296 (Pubitemid 24261839)
26. Traiffort E, Ruat M, O'Regan S, et al. (2005) Molecular characterization of the family of choline transporterlike proteins and their variants. J Neurochem 92:1116-1125 (Pubitemid 40344302)
27. Yuan Z, Tie A, Tarnopolski M (2006) Genomic organization, promoter activity, and expression of the human choline transporter-like protein 1. Physiol Genomics 16:76-90 (Pubitemid 43974224)
28. Ahrén, B (2000) Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 43:393-410 (Pubitemid 30237947)
29. Gilon P, Henquin JC (2001) Mechanism and physiological significance of the cholinergic control of pancreatic b-cell function. Endoc Rev 22:565-604 (Pubitemid 32958576)
30. Ilcol YO, Gurun MS, Taga Y, et al. (2003) Choline increases serum insulin in rat when injected intraperitoneally and augments basal and stimulated aceylcholine release from the rat minced pancreas in vitro. Eur J Biochem 270:991-999 (Pubitemid 36315342)
31. Esslimani-Sahla M, Thezenas S, Simony-Lafontaine J (2007) Increased expression of fatty acid synthase and progesterone receptor in early steps of human mammary carcinogenesis. Int J Cancer 120:224-229 (Pubitemid 44970426)
32. Hochachka PW, Rupert JL, Goldenberg L, et al. (2002) Going malignant: The hypoxia-cancer connection in the prostate. Bioessays 24:749-757 (Pubitemid 34850332)